ThromboVision is a biomedical company providing versatile clinical discoveries for the advancement of medical diagnosis.
ThromboVision is a biomedical company committed to enabling people to lead longer and healthier lives. ThromboVision provides easy-to-use, rapid-response, cost-effective, and versatile clini cal diagnostic discoveries that advance medical diagnosis. The company's products will improve medical care by assisting physicians in diagnosing and managing critical cardiovascular risk factors, especially those related to platelet function and antiplatelet drug therapy.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 13, 2007 | Series A | $4M | 1 | National Healthcare Services | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Healthcare Services | Yes | Series A |